Pembrolizumab-induced sarcoid-like reaction

Last revised by Henry Knipe on 16 Sep 2022

Citation, DOI, disclosures and article data

Citation:

Weerakkody Y, Knipe H, Pembrolizumab-induced sarcoid-like reaction. Reference article, Radiopaedia.org (Accessed on 18 Apr 2024) https://doi.org/10.53347/rID-79092

DOI:

https://doi.org/10.53347/rID-79092

Permalink:

https://radiopaedia.org/articles/79092

rID:

79092

Article created:

19 Jun 2020, Yuranga Weerakkody ◉

Disclosures:

At the time the article was created Yuranga Weerakkody had no recorded disclosures.

View Yuranga Weerakkody's current disclosures

Last revised:

16 Sep 2022, Henry Knipe ◉ ◈

Disclosures:

At the time the article was last revised Henry Knipe had the following disclosures:

Radiopaedia Events Pty Ltd, Speaker fees (past)
Integral Diagnostics, Shareholder (ongoing)
Micro-X Ltd, Shareholder (ongoing)

These were assessed during peer review and were determined to not be relevant to the changes that were made.

View Henry Knipe's current disclosures

Revisions:

2 times, by 2 contributors - see full revision history and disclosures

Systems:

Chest

Tags:

cases, case3, refs

Synonyms:

Pembrolizumab induced sarcoid like reactions

Pembrolizumab-induced sarcoid-like reaction is a recently (c.2019) reported phenomenon which has been associated with the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It could be mistaken for metastatic disease in some situations.